Cytokinetics, IncorporatedCYTKNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank43
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P43
Within normal range
vs 5Y Ago
-1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-24.33%
20243.49%
2023-25.87%
2022-54.64%
2021-42.13%
202023.94%
2019-32.82%
201824.71%
2017-731.71%
2016142.27%